XML 48 R38.htm IDEA: XBRL DOCUMENT v3.24.3
Related Party Transactions - Narrative (Details)
3 Months Ended
Dec. 14, 2023
USD ($)
Nov. 22, 2023
$ / shares
shares
Jul. 12, 2023
USD ($)
Mar. 31, 2024
USD ($)
seat
shares
Mar. 31, 2023
USD ($)
shares
Dec. 31, 2023
USD ($)
Jul. 31, 2023
USD ($)
Related Party Transaction [Line Items]              
Stock-based compensation       $ 13,835,000 $ 1,709,000    
Related party accounts payable and other current liabilities       $ 15,528,000   $ 16,584,000  
Options granted (in shares) | shares       1,044,658 177,620    
Stock-based compensation expense       $ 13,835,000 $ 1,709,000    
Paragon Agreement              
Related Party Transaction [Line Items]              
Number of board seats held by related party | seat       2      
Related Party              
Related Party Transaction [Line Items]              
Related party accounts payable and other current liabilities       $ 15,500,000   16,600,000  
Related Party | Paragon Agreement              
Related Party Transaction [Line Items]              
Amount of related party transaction       18,200,000      
Stock-based compensation       5,400,000      
Related party accounts payable and other current liabilities       $ 10,100,000   $ 16,600,000  
Common stock, shares outstanding, percentage available to purchase on a diluted basis       1.00%      
Related Party | Subsequent to Asset Acquisition              
Related Party Transaction [Line Items]              
Amount of related party transaction       $ 17,100,000      
Related Party | SPY001 License Agreement              
Related Party Transaction [Line Items]              
Nomination fee     $ 1,500,000        
First milestone payment     $ 2,500,000        
Related Party | SPY002 License Agreement              
Related Party Transaction [Line Items]              
Nomination fee $ 1,500,000            
First milestone payment $ 2,500,000            
Sublicensing fee, maximum amount       20,000,000.0      
Related Party | Consulting Agreement              
Related Party Transaction [Line Items]              
Options granted (in shares) | shares   477,000          
Exercise price (in dollars per share) | $ / shares   $ 10.39          
Vesting period   36 months          
Stock-based compensation expense       $ 300,000 $ 0    
Related Party | Consulting Agreement | Share-Based Payment Arrangement, Tranche One              
Related Party Transaction [Line Items]              
Vesting percentage   25.00%          
Vesting period   1 year          
Paragon Therapeutics Inc | Maximum | Related Party | Paragon Agreement              
Related Party Transaction [Line Items]              
Percentage of ownership by noncontrolling owner       5.00%      
Paragon Therapeutics Inc | Maximum | Related Party | SPY001 License Agreement              
Related Party Transaction [Line Items]              
Contingent obligation based on milestones             $ 22,000,000.0
Fairmount Funds Management LLC | Minimum | Related Party | Paragon Agreement              
Related Party Transaction [Line Items]              
Percentage of ownership by noncontrolling owner       5.00%      
Percentage of ownership held in third party       5.00%